LONDON (AP) — King Charles III returned to public duties on Tuesday, visiting a cancer treatment charity and beginning his ...

Apr. 29, 2024 — Researchers have developed a model of Kaposi sarcoma that could expedite the development of new drugs to treat the disease, which is the most common cancer in people living with ...

Corner office? Coming right up! Today, your career trajectory will be on an upswing, thanks to bold Mars in your ambition arena high-fiving powerful Pluto. Maybe a plum assignment lands on your ...

Lip cancer is a form of cancer that starts in the lips and mouth. Early signs and symptoms can include sores or lumps on the lips or in the mouth. Treatment will depend on the size and location of ...

Adding olaparib to maintenance therapy with bevacizumab was associated with significantly longer survival for patients with ...

Androgen deprivation is the mainstay of advanced prostate cancer treatment. Despite initial responses, almost all patients progress to castration-resistant prostate cancer (CRPC). The ...

Noticing a mysterious spot on your skin can trigger an anxiety-inducing mental debate: Is it just a harmless growth or something more sinister? Detecting a potentially cancerous mole can be difficult ...

metastatic or recurrent biliary tract cancer (N=24). Findings showed an overall response rate (ORR) of 37.5% (95% CI, 18.8-59.4). Median duration of response and progression free survival were 9.4 ...

Britain's King Charles III, holding a bunch of flowers, waves to crowds after to visit to the University College Hospital ...

November is Pancreatic Cancer Awareness Month, which makes this a good time to learn more about the risk factors for pancreatic cancer and what you can do to keep yourself safe. More than 64,000 ...

However, higher CRF predicted a higher hazard of being diagnosed with prostate cancer (n=14 232, HR 1.07, 95% CI 1.03 to 1.12) and malignant skin cancer (n=23 064, HR 1.31, 95% CI 1.27 to 1.36).

Apr. 18, 2024 — Researchers have developed a new urine-based test that addresses a major problem in prostate cancer: how to separate the slow-growing form of the disease unlikely to cause harm ...